Healthcare Today Bahrain
SEE OTHER BRANDS

Get your health and wellness news from Bahrain

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Today Bahrain.

Anker SOLIX Joins Military Makeover to Support  Air Force Veteran with Home Energy Upgrade
Venous Stents Market To Reach US$ 2.31 Billion By 2032, Driven By Advancements In Vascular Treatments
Tumor Ablation Market Set For Significant Growth, Expected To Hit USD 4,389 Million By 2032
Acne Treatment Market Set To Grow At 5.4% CAGR, Expected To Hit USD 16.2 Billion By 2032
Clinical Trial Imaging Market To Expand At A 7.8% CAGR, Reaching US$ 2,219.8 Million By 2032
Ovarian Cancer Drugs Market To Reach USD 9,857 Million By 2032, Growing At A 14.3% CAGR
Human Insulin Market Projected to Achieve USD 46.7 Billion by 2033, Fueled by Advancements in Insulin Therapy
Diagnostic Ultrasound Market Poised For Strong Growth, Projected To Reach USD 11.1 Billion By 2032
Hemostat Market To Achieve USD 5.7 Billion By 2033, Growing At A Robust 6.4% CAGR
Human Papillomavirus (HPV) Testing Market Projected To Reach USD 13.9 Billion By 2032
Protein Engineering Market To Witness Accelerated Growth, Forecasted to Reach USD 9,329 Million By 2032
Cardiovascular Drugs Market to See Strong Growth, Surpassing USD 203.6 Billion by 2033
Acute Ischemic Stroke Therapeutics Market To Reach USD 14.0 Billion By 2032, Backed By Rising Incidence Of Stroke
Compression Therapy Market Growth Accelerates, Surpassing USD 7.3 Billion by 2033
Veterinary Electrosurgery Market to Reach USD 1000.9 Million by 2032, Growing at a 7.0% CAGR
Radiation Oncology Market To Reach USD 19.2 Billion By 2032, Growing At 9.1% CAGR
Artificial Intelligence In Oncology Market Expected To Surge USD 13,619.8 Million By 2032
Small Molecule Drug Discovery Market Growth Expected to Reach USD 121.8 Billion by 2033
Biopharmaceutical CMO Market Set To Grow To USD 51.5 Billion By 2032, Powered By 12.6% CAGR
Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions